[Evaluation of the therapeutic possibilities offered by the combination: substrates of the Krebs-Henseleit cycle and vitamins in hepatic toxicoses].
D000328:Adult; D000368:Aged; D001120:Arginine / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000188:drug therapy*; D002956:Citrulline / Q000627:therapeutic use*; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009536:Niacinamide / Q000627:therapeutic use*; D009952:Ornithine / Q000627:therapeutic use*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D009536:Niacinamide; D002956:Citrulline; D005492:Folic Acid; D001120:Arginine; D009952:Ornithine; D014805:Vitamin B 12
Valutazione delle possibilità terapeutiche offerte dall'associazione: substrati dei ciclo di Krebs-Henseleit/vitamine nelle tossicosi epatiche.